Paxil vs Zoloft: Why Half-Life Changes the Choice
Clinically reviewed by Daniel Montville, MD
Reviewed October 21, 2026 · Last updated September 28, 2026
Key Takeaways
- Paxil and Zoloft worked about equally well in head-to-head trials for depression and panic disorder, so the practical differences matter more than raw effectiveness.
- In a controlled interruption trial, paroxetine caused new symptoms after the second missed dose, while sertraline caused milder changes limited to a few symptoms over 5 days.
- In a panic disorder trial, the share of panic-free patients fell 11% during a paroxetine taper but rose 4% during a sertraline taper.
- Paroxetine was linked to more weight gain than sertraline in two randomized trials, and its label carries a first-trimester cardiac malformation warning.
Maybe your prescriber mentioned both, and you’re trying to understand what actually separates them. Or you’ve been on Paxil for years and wonder whether Zoloft would be easier to live with. Both are SSRIs, both treat depression and several anxiety disorders, and both work. The real differences show up on the days you forget a pill and on the day you decide to stop.
Your brain adapts to an SSRI over months, and it notices when the drug’s levels drop. The Paxil prescribing information gives paroxetine a half-life of about 21 hours with essentially inactive metabolites, while the Zoloft prescribing information puts sertraline at about 26 hours. Those numbers look close, but they play out very differently, so choosing between these two takes precision about how each one leaves your body.
On effectiveness, the evidence is reassuring for both. In a 24-week head-to-head trial of 353 people with depression, sertraline and paroxetine showed comparable efficacy, with remission rising to 80% and 74% by the end. A 12-week panic trial found the same, with 82% of sertraline patients and 78% of paroxetine patients rated as responders. The results are real, and the evidence is well established.
But equal efficacy isn’t the whole decision, and at Siggy we think the realities of daily life belong in the choice. Comparing these drugs by half-life means looking at how each behaves when a dose is missed and how hard each is to stop, alongside weight, sexual side effects, pregnancy, and drug interactions. It answers the same question, which SSRI fits you, with more precision than an efficacy table alone. The biggest difference between Paxil and Zoloft is pharmacology.
What This Page Covers
- Paxil and Zoloft at a Glance
- Do They Work Equally Well?
- What Happens When You Miss a Dose
- Which Is Harder to Stop?
- Weight and Sexual Side Effects
- Pregnancy and Drug Interactions
- Who Might Lean Toward Each
Paxil and Zoloft at a Glance
Here’s how the two compare, drawing on their FDA labels and the head-to-head trials below:
| Feature | Paxil (Paroxetine) | Zoloft (Sertraline) |
|---|---|---|
| Half-life | About 21 hours | About 26 hours |
| Active metabolite | Essentially none | Weakly active, 62 to 104 hours |
| FDA-approved uses | MDD, OCD, panic, social anxiety, GAD, PTSD | MDD, OCD, panic, social anxiety, PTSD, PMDD |
| Usual adult start | 20 mg (10 mg for panic) | 50 mg (25 mg for panic, PTSD, social anxiety) |
| Missed-dose symptoms | After about 2 missed doses | Milder, fewer symptoms |
| Weight gain in trials | Significant | Not significant |
| First-trimester label note | Cardiac malformation warning | No overall birth defect signal |
Do They Work Equally Well?
For most people, yes. Beyond the two head-to-head trials above, a network meta-analysis of 522 trials found every antidepressant studied worked better than placebo for depression. Paroxetine was among the more effective drugs in head-to-head comparisons, and sertraline was among the more tolerable ones.
In the 24-week depression trial, 2% of sertraline patients and 9% of paroxetine patients relapsed during continuation treatment, and the authors described sertraline as having a somewhat lower side effect profile. Both drugs were well tolerated, so that relapse difference is worth noting without over-reading it.
What Happens When You Miss a Dose
This is where half-life shows up. In a double-blind interruption trial, people stable on an SSRI had their medication secretly swapped for placebo for 5 days. On paroxetine, new symptoms appeared after the second missed dose, and 13 of 17 tracked symptoms worsened. On sertraline, only 3 of 17 worsened: dizziness, nausea, and unusual dreams.
The paroxetine group also had significant increases in depression and anxiety scores and reported worse functioning at work, in relationships, and in social life. The sertraline group’s depression and anxiety scores didn’t rise significantly. Blood levels fell about 87% on paroxetine and about 74% on sertraline over those 5 days.
A 4-to-7-day interruption study found the same split, with more cognitive failures, poorer sleep, and more depressive symptoms after stopping paroxetine, effects that weren’t evident with sertraline. If you’re on Zoloft, our guide to what to do after a missed dose of Zoloft walks through the timing.
Which Is Harder to Stop?
Paxil, by most measures. In the panic disorder trial, both drugs were tapered over 3 weeks at the end. During that taper, the share of panic-free patients rose by 4% with sertraline and fell by 11% with paroxetine, a significant difference.
A 2024 meta-analysis of 79 studies listed paroxetine among the antidepressants linked to more severe discontinuation symptoms. Sertraline isn’t free of them, though. Its label lists dizziness, nausea, irritability, and electric shock sensations among possible symptoms, particularly after abrupt stopping.
Both labels recommend reducing the dose gradually. The Paxil label notes that its anxiety and PTSD trials lowered the dose by 10 mg a week and held 20 mg for a week before stopping. Our guides on Paxil withdrawal and tapering off Zoloft go deeper on each.
Weight and Sexual Side Effects
Weight is the clearest difference. In a 26-to-32-week randomized trial, paroxetine was linked to significant weight gain, sertraline to a modest gain that wasn’t significant, and more paroxetine patients gained at least 7% of their body weight. The panic disorder trial echoed this: 7% of paroxetine patients gained that much, compared with less than 1% on sertraline.
Both drugs can cause sexual side effects. In the Paxil label’s trials, ejaculatory problems affected 13% to 28% of men, compared with 0% to 2% on placebo. In the Zoloft label’s trials, ejaculation failure affected 8% of men, compared with 1% on placebo. These figures come from different trials, so they hint at a difference without proving one.
Sleepiness is another consideration. In Paxil’s depression trials, 23% of people reported somnolence, compared with 9% on placebo. Some people find that helpful at first, and others find it hard to live with.
Pregnancy and Drug Interactions
The Paxil label warns that first-trimester exposure is associated with a less than 2-fold increase in cardiovascular malformations, and it advises starting paroxetine in early pregnancy only after considering other options. The Zoloft label says studies of first-trimester sertraline exposure suggest no difference in major birth defect risk compared with background rates. Our guide to antidepressants and pregnancy covers the wider evidence.
Paroxetine is also a strong blocker of CYP2D6, a liver enzyme that clears many drugs. The Paxil label advises considering a different antidepressant for people taking tamoxifen. The Zoloft label notes that sertraline’s effect on CYP2D6 is less prominent at lower doses, though it can still matter. Bring a full medication list to any conversation about switching.
Who Might Lean Toward Each
These are considerations to discuss with your prescriber, not a formula:
- Zoloft may fit better if you sometimes miss doses, might want to stop in the future, are planning a pregnancy, take tamoxifen or other CYP2D6-dependent drugs, or have PMDD.
- Paxil may fit better if you’ve responded well to it before or have generalized anxiety disorder, which is on its FDA label and not Zoloft’s.
- Either way, your history with past medications matters more than any comparison chart.
With Paxil especially, a few missed doses can bring on symptoms within days, and waiting weeks to ask about it is hard.
Paxil and Zoloft work about equally well, so the choice usually comes down to daily life: Zoloft is more forgiving of missed doses and easier to stop, while Paxil has a broader anxiety label and more weight gain and pregnancy caution. If you’re weighing other options too, our look at SSRI medications compared puts both in context with the rest of the class.
Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.
If you have thoughts of harming yourself, call or text 988. If you’re in immediate danger, call 911.
This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
Which is better, Paxil or Zoloft?
Neither is better for everyone. Head-to-head trials found similar effectiveness for depression and panic disorder. Zoloft tends to be easier to live with if you sometimes miss doses or may want to stop later, while Paxil is FDA-approved for generalized anxiety disorder and may suit people who responded well to it before.
Why is Paxil harder to stop than Zoloft?
Paroxetine clears faster in practice. Its half-life is about 21 hours with essentially inactive metabolites, and in an interruption trial its blood levels fell about 87% over 5 days, compared with about 74% for sertraline. Paroxetine users developed symptoms after the second missed dose.
Does Paxil cause more weight gain than Zoloft?
The trial evidence says yes. In a 26-to-32-week randomized trial, paroxetine was linked to significant weight gain while sertraline was not, and more paroxetine patients gained at least 7% of their body weight. A panic disorder trial found 7% vs less than 1% had that much gain.
Is Zoloft or Paxil safer during pregnancy?
The labels are more reassuring for Zoloft. The Paxil label warns that first-trimester exposure is associated with a less than 2-fold increase in cardiovascular malformations. The Zoloft label says studies of first-trimester sertraline exposure suggest no difference in major birth defect risk. Discuss any change with your prescriber first.
Can I switch from Paxil to Zoloft?
Yes, with your prescriber's guidance. Because paroxetine can cause discontinuation symptoms when stopped quickly, switches are usually planned rather than abrupt. Paroxetine also blocks the CYP2D6 liver enzyme, so other medications you take may need review during the change.
Does Paxil or Zoloft cause more sexual side effects?
Both can. In their labels' trials, ejaculatory problems affected 13% to 28% of men on Paxil and ejaculation failure affected 8% of men on Zoloft, though these came from different trials that can't be compared directly. Tell your prescriber about any changes, since there are ways to manage them.
Sources
- U.S. National Library of Medicine. Paxil (paroxetine) Tablets and Oral Suspension Prescribing Information. DailyMed. dailymed.nlm.nih.gov
- U.S. National Library of Medicine. Zoloft (sertraline hydrochloride) Tablets and Oral Solution Prescribing Information. DailyMed. dailymed.nlm.nih.gov
- Aberg-Wistedt A, Agren H, Ekselius L, Bengtsson F, Akerblad AC. Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy. Journal of Clinical Psychopharmacology. 2000;20(6):645-652. doi:10.1097/00004714-200012000-00010
- Bandelow B, Behnke K, Lenoir S, et al. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison. Journal of Clinical Psychiatry. 2004;65(3):405-413. doi:10.4088/jcp.v65n0317
- Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018;391(10128):1357-1366. doi:10.1016/S0140-6736(17)32802-7
- Michelson D, Fava M, Amsterdam J, et al. Interruption of selective serotonin reuptake inhibitor treatment: double-blind, placebo-controlled trial. British Journal of Psychiatry. 2000;176:363-368. doi:10.1192/bjp.176.4.363
- Hindmarch I, Kimber S, Cockle SM. Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. International Clinical Psychopharmacology. 2000;15(6):305-318. doi:10.1097/00004850-200015060-00001
- Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The Lancet Psychiatry. 2024;11(7):526-535. doi:10.1016/S2215-0366(24)00133-0
- Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment. Journal of Clinical Psychiatry. 2000;61(11):863-867. doi:10.4088/jcp.v61n1109